The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preoperative camrelizumab combined with chemotherapy for borderline resectable esophageal squamous cell carcinoma (BRES-1): A single-arm, open-label, phase II study.
 
Hang Yang
No Relationships to Disclose
 
Guoqing Zhang
No Relationships to Disclose
 
Xiangnan Li
No Relationships to Disclose
 
Jia Jiao
No Relationships to Disclose
 
Yanan Guo
No Relationships to Disclose
 
Yan Zhang
No Relationships to Disclose
 
Zhichao Hou
No Relationships to Disclose
 
Qi Huang
No Relationships to Disclose
 
Jia Zhao
No Relationships to Disclose
 
Jindong Li
No Relationships to Disclose